Derek Wiswell

1.4k citations
15 papers · 1.2k · 1 hit paper · h-index 13

Impact in

  • Oncology top 10%
    • Cancer-related Molecular Pathways
    • Synthesis and biological activity
    • Synthesis and Characterization of Heterocyclic Compounds

Papers in

    • Synthesis and biological activity 7
    • Synthesis and Characterization of Heterocyclic Compounds 3
    • Cancer-related Molecular Pathways 3
    • Cancer Immunotherapy and Biomarkers 1

Derek Wiswell

15 papers receiving 1.2k citations

Derek Wiswell's Hit Papers

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor 2010 · 484 citations
4840+5+10Years since publication100200300400

Peers

Derek Wiswell
Comparison fields: 5 of 58
  • Oncology 313
  • Organic Chemistry 351
  • Computational Theory and Mathematics 139
  • Genetics 57
  • Molecular Biology 357
Replace Bernard C. Barlaam with:
Bernard C. Barlaam United Kingdom
Marina Ciomei Italy
Christina Esdar Germany
Francesco Sola Italy
Rebecca P.A. Ellston United Kingdom
Matthias Hoffmann Germany
André Richters Germany
Jürgen K. Moll Italy
Jimmy A. Blair United States
Cédric Barrière France
Derek Wiswell relative to Bernard C. Barlaam United Kingdom Bernard C. Barlaam's profile →
Citations per field
00.5×1.5×
Bernard C. Barlaam · 1×
Citations per year

Countries citing papers authored by Derek Wiswell

Since Specialization
Citations

This map shows the geographic impact of Derek Wiswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Wiswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Wiswell more than expected).

Fields of papers citing papers by Derek Wiswell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Wiswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Wiswell. The network helps show where Derek Wiswell may publish in the future.

Co-authors

The 25 scholars most cited alongside Derek Wiswell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Derek Wiswell Line = papers co-authored together Derek Wiswell links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
Hit paper breakdown →
2010484
2 2011155
3 2010154
4 201983
5 201067
6 201060
7 200753
8 201037
9 201534
10 200431
11 200731
12 201329
13 201514
14 20209
15 20214

About Derek Wiswell

Derek Wiswell is a scholar working on Organic Chemistry, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Cancer-related Molecular Pathways (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Advanced Breast Cancer Therapies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Oncology (313 citations), Organic Chemistry (351 citations), Computational Theory and Mathematics (139 citations), Genetics (57 citations) and Molecular Biology (357 citations). Derek Wiswell has collaborated with scholars based in United States and Italy. Frequent co-authors include Wolfgang Seghezzi, Timothy J. Guzi, Nicole M. Davis, Kamil Paruch, Michael P. Dwyer, Thierry O. Fischmann, Emma M. Lees, Ronald J. Doll, Deepa Prabhavalkar and Taiying Chen. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Molecular and Cellular Biology, ACS Medicinal Chemistry Letters and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact